Difference between revisions of "Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5 (Q9625)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2017, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Pharmacol. Ther., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Pharmacol. Ther. | ||
| Property / Published In Name String: Pharmacol. Ther. / rank | |||
| + | Normal rank | ||
Revision as of 20:38, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Dey N
0 references
De P
0 references
Leyland-Jones B
0 references
2017
0 references
Pharmacol. Ther.
0 references
